Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20034276HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034277HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034280HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047208HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034278HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034282HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034283HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047211HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20047209HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TVIS20034281HPVENSG00000179546.5protein_codingHTR1DNoNo3352P28221
TCGA Plot Options
Drug Information
GeneHTR1D
DrugBank IDDB01186
Drug NamePergolide
Target IDBE0000659
UniProt IDP28221
Regulation Typeagonist
PubMed IDs18691132; 10641988
CitationsKvernmo T, Houben J, Sylte I: Receptor-binding and pharmacokinetic properties of dopaminergic agonists. Curr Top Med Chem. 2008;8(12):1049-67.@@Lam YW: Clinical pharmacology of dopamine agonists. Pharmacotherapy. 2000 Jan;20(1 Pt 2):17S-25S.
GroupsApproved; Investigational; Vet_approved; Withdrawn
Direct ClassificationIndoloquinolines
SMILES[H][C@@]12CC3=CNC4=CC=CC(=C34)[C@@]1([H])C[C@@H](CSC)CN2CCC
Pathways
PharmGKBPA450873
ChEMBLCHEMBL531